DURACLON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Duraclon, and when can generic versions of Duraclon launch?
Duraclon is a drug marketed by Mylan Institutional and is included in one NDA.
The generic ingredient in DURACLON is clonidine hydrochloride. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clonidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duraclon
A generic version of DURACLON was approved as clonidine hydrochloride by ACTAVIS ELIZABETH on December 16th, 1986.
Summary for DURACLON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 9 |
| Patent Applications: | 5,551 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DURACLON |
| What excipients (inactive ingredients) are in DURACLON? | DURACLON excipients list |
| DailyMed Link: | DURACLON at DailyMed |
Recent Clinical Trials for DURACLON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kootenai Health | Phase 4 |
| University of Louisville | Phase 4 |
| Arthroplasty Foundation, Inc. | Phase 4 |
Pharmacology for DURACLON
| Drug Class | Central alpha-2 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha2-Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DURACLON
US Patents and Regulatory Information for DURACLON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | DURACLON | clonidine hydrochloride | INJECTABLE;INJECTION | 020615-001 | Oct 2, 1996 | AP | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan Institutional | DURACLON | clonidine hydrochloride | INJECTABLE;INJECTION | 020615-002 | Apr 27, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
